Niederer Kraft Frey advised Demathieu Bard on the deal, while Walder Wyss acted for Steiner AG. Demathieu Bard completed the acquisition of Steiner Construction SA. Steiner...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Mökah AG as legal counsel on the transaction. Mökah AG, a company of the Kanalservice Group and portfolio company of Ufenau Capital Partners,...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Banca Generali SpA, Milan, on its expansion into the Swiss market through BG (Suisse) Private Bank SA. Banca Generali SpA (BGN.MI), a leading...
You must be a Standard 1 Year member to access this content.
Niederer Kraft Frey advised Rayner Group on the deal. Walder Wyss advised Multimed AG. Rayner Group acquired This AG from the private investment company Multimed AG and accompanied...
You must be a Standard 1 Year member to access this content.
Walder Wyss advises LEND on Series C Financing Round The Swiss FinTech Start-Up LEND has successfully completed a Series C financing round of CHF 2,5 million....
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Green Landscaping Group AB (publ) on this transaction. Green Landscaping Group (Publ) continues the expansion journey in Europe and acquires Viva Gartenbau AG,...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Vandria SA in this transaction. Vandria SA, a company developing mitochondrial therapeutics, including first-in-class small molecule mitophagy inducers, today emerged from stealth with...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Axalta Coating Systems on this transaction. Axalta Coating Systems Group (NYSE: AXTA) acquired André Koch AG, an established provider of car repair and...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Nasdaq listed Altamira Therapeutics. Altamira Therapeutics Ltd. (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, entered into a binding...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised the sellers in this matter. The Cendres+Métaux Group acquired 100% of the shares in Lauener & Cie SA, based in Boudry NE. Lauener...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Boehringer Ingelheim in the transaction. Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG, a clinical stage Swiss biotech company, for an...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised the investors while VISCHER acted as legal advisor to Nouscom in the transaction. Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized...
You must be a Standard 1 Year member to access this content.
